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Background: During the last two decades many efforts have been directed towards obtaining efficient microbial
processes for the production of shikimic acid (SA); however, feeding high amounts of substrate to increase the titer
of this compound has invariably rendered low conversion yields, leaving room for improvement of the producing
strains. In this work we report an alternative platform to overproduce SA in a laboratory-evolved Escherichia coli
strain, based on plasmid-driven constitutive expression of six genes selected from the pentose phosphate and
aromatic amino acid pathways, artificially arranged as an operon. Production strains also carried inactivated genes
coding for phosphotransferase system components (ptsHIcrr), shikimate kinases I and II (aroK and aroL), pyruvate
kinase I (pykF) and the lactose operon repressor (lacI).
Results: The strong and constitutive expression of the constructed operon permitted SA production from the
beginning of the cultures, as evidenced in 1 L batch-mode fermentors starting with high concentrations of glucose
and yeast extract. Inactivation of the pykF gene improved SA production under the evaluated conditions by
increasing the titer, yield and productivity of this metabolite compared to the isogenic pykF+ strain. The best
producing strain accumulated up to 43 g/L of SA in 30 h and relatively low concentrations of acetate and aromatic
byproducts were detected, with SA accounting for 80% of the produced aromatic compounds. These results were
consistent with high expression levels of the glycolytic pathway and synthetic operon genes from the beginning of
fermentations, as revealed by transcriptomic analysis. Despite the consumption of 100 g/L of glucose, the yields on
glucose of SA and of total aromatic compounds were about 50% and 60% of the theoretical maximum,
respectively. The obtained yields and specific production and consumption rates proved to be constant with three
different substrate concentrations.
Conclusions: The developed production system allowed continuous SA accumulation until glucose exhaustion and
eliminated the requirement for culture inducers. The obtained SA titers and yields represent the highest reported
values for a high-substrate batch process, postulating the strategy described in this report as an interesting
alternative to the traditionally employed fed-batch processes for SA production.
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Shikimic acid (SA) is an intermediate compound in the
aromatic amino acid (AAA) biosynthetic pathway in plants
and bacteria (Figure 1). This metabolite is utilized as
starting material in the chemical synthesis of oseltamivir
phosphate (Tamiflu), used for influenza treatment [1-3].
Several genetic strategies have been reported for improving
SA productivity and yield in Escherichia coli. These
strategies aim to increase the availability of the direct
precursors of the AAA pathway, erythrose 4-phosphate
(E4P) and phosphoenolpyruvate (PEP), by genetic alter-
ations that promote a convenient redistribution of carbon
fluxes in the central metabolism [4,5]. Complementary
approaches include the interruption of the AAA pathway
after SA formation by inactivation of the genes coding forFigure 1 Genetic modifications applied in this report to enhance the pro
strain PB12. Inactivated genes are indicated with a cross and plasmid-expresse
than one catalytic step. G6P = glucose 6-phosphate; F6P = fructose 6-phosphate
Ru5P = ribulose 5-phosphate; R5P = ribose 5-phosphate; Xu5P = xylulose 5-phos
PEP = phosphoenolpyruvate; PYR = pyruvate; ACoA = acetyl-coenzyme A; Ace-P
arabinoheptulosonate 7-phosphate; DHQ= 3-dehydroquinic acid; DHS = 3-dehy
S3P = shikimate 3-phosphate; CHO= chorismate; IICBGlc =membrane compone
histidine protein; IIAGlc = cytosolic component of glucose-specific PTS permease
permease; glk, glucokinase; pgi, phosphoglucose isomerase; pfkA, 6-phosphofruc
glyceraldehyde 3-phosphate dehydrogenase; eno, enolase; actP, acetate permea
ackA, acetate kinase; poxB, pyruvate oxidase.shikimate kinases (aroK and aroL), as well as enhance-
ments in carbon channeling towards SA by overexpression
of feedback-resistant DAHP synthases, shikimate dehydro-
genase, transketolase, and DHQ synthase enzymes (coded
by aroFGHfbr, aroE, tktA, and aroB, respectively) (Figure 1)
[6-9]. In an attempt to further increase the intracellular
availability of PEP, strains overexpressing PEP syn-
thase (coded by ppsA), or lacking the PEP:carbohydrate
phosphotransferase system (PTS) and the pyruvate
kinase isozymes (coded by pykF and pykA), have also
been evaluated (Figure 1) [10-13].
Although the implementation of these modifications
along with bioengineering strategies has led to diverse
E. coli strains capable of accumulating SA, the yields
obtained to date are still far from the theoretical maximumduction of shikimic acid from glucose in the laboratory-evolved E. coli
d genes are circled (see Methods for details). Dashed arrows indicate more
; GAP = glyceraldehyde 3-phosphate; 6PGNL = 6-phosphogluconolactone;
phate; S7P = sedoheptulose 7-phosphate; E4P = erythrose 4-phosphate;
= acetyl phosphate; CIT = citrate; OAA = oxaloacetate; DAHP = 3-deoxy-D-
droshikimic acid; QA= quinic acid; GA = gallic acid; SA = shikimic acid;
nt of glucose-specific PTS permease; E1 = PTS enzyme 1; Hpr = PTS
. Genes coding for enzymes not named in the figure: galP, galactose
tokinase I; fbaA, fructose bisphosphate aldolase class II; gapA,
se; acs, acetyl-coenzyme A synthetase; pta, phosphate acetyltransferase;
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that most expression systems used involve genes controlled
by a mixture of inducible and native promoters of variable
strengths, contained in more than one type of plasmid.
These imbalances often cause a metabolic burden and
heterogeneities on the intensity and temporality of
gene expression, which may translate into suboptimal
production capabilities of the recombinant strains,
resulting in low productivity and yield of SA [16-19].
Consequently, optimized DNA expression systems and
genetic backgrounds are needed for promoting a more
efficient carbon channeling towards SA formation.
With the goal of producing aromatic compounds, our
group has constructed and characterized strains lacking
PTS, the major glucose transport system [20]. One of
such strains is PB11, which grows poorly on glucose
due to the inactivation of PTS [21,22]. Strain PB12, a
derivative of PB11 with a 400% increased growth rate,
was isolated in a short laboratory adaptive evolution
process to foster derivatives growing in glucose [21,22].
This strain can simultaneously utilize glucose and other
carbon sources (acetate, glycerol and various carbohydrates)
in minimal medium due to the lack of catabolite repression
exerted by PTS [21,23]. Whole genome analysis allowed the
identification of the genetic changes that occurred in PB12,
suggesting that the deletion of 12 genes, including rppH,
galR and mutH, is the main reason for its rapid growth on
glucose [24].
It was reported that PB12, which assimilates glucose
by the non-PTS symporter GalP [25], can be engineered
to accumulate SA in culture media containing glucose
(Glc) and yeast extract (YE). For instance, when PB12
was transformed with two plasmids encoding four
biosynthetic genes, the variant with both functional
pyruvate kinases accumulated the highest SA concentration
(up to 7 g/L), but the highest yield of aromatic compounds
was achieved by a derivative with an inactivated pykF gene
[11]. This result may be related to other reported effects
caused by the inactivation of pykF, such as an increase in
plasmid copy number per cell [26], low acetate production
due to less glycolytic overflux [13,27,28], or higher concen-
trations of the AAA pathway enzymes [29]. Interestingly, in
spite of the aforesaid features that can be beneficial
for SA production, the metabolic engineering efforts
to overproduce this compound have been mainly applied
to strains with a pykF+ background, probably because of
their typically higher glucose consumption rates compared
to the pykF- counterparts [11,30].
Here, we propose that a PTS- pykF- strain has the
potential to increase the yield and titer of SA when
compared to an isogenic pykF+ strain, provided that
the gene expression system permits an appropriate
temporal coordination in the synthesis of the enzymes
required to channel the carbon towards SA, while reducingthe accumulation of acetate and intermediate compounds
in the AAA pathway. In order to accomplish this goal a
synthetic operon was constructed containing the coding
sequences of six genes selected from the pentose
phosphate (PPP) and AAA pathways (Figure 1), controlled
by a single constitutive Trc promoter [31] and inserted it
into a high-copy plasmid containing a region that confers
segregational stability (Figure 2) [32]. The resulting
plasmid was transformed into a modified PB12 strain
with inactive aroK, aroL, pykF, and lacI genes, and was
cultured in fermentors using mineral media containing
Glc and supplemented with YE. Overall, the strategy
proposed in this report allowed the overproduction of SA
from the beginning of the culture, resulting in a high titer
and yield of SA with relatively low accumulation of acetate
and aromatic byproducts. It was also found that, under
the high-substrate conditions tested, the SA titer was
independent of the YE concentration and the maximum
biomass produced depended exclusively on the initial YE
concentration but not on the amount of glucose.
Results and discussion
Construction of strains derived from PB12 aroK- aroL-
containing a plasmid designed for the constitutive
expression of a synthetic operon used in the production
of shikimic acid
Unpublished evidence from our laboratory indicates
that the production of aromatic compounds in the
laboratory-evolved strain PB12 can attain higher levels
when the transcriptional induction of the genes involved in
canalizing carbon flux into the AAA pathway occurs at the
beginning of fermentations. Taking into account this ob-
servation, a new strategy was developed for optimizing
the production of SA in PB12 carrying inactive aroK and
aroL genes (Figure 1). This strategy included the design
and construction of a plasmid for the strong and stable ex-
pression of six key genes arranged in the form of a syn-
thetic operon, controlled exclusively by a single Trc
promoter. In order to reduce metabolic burden, a single
plasmid derived from pBR327 carrying the par locus
for increased plasmid stability was utilized as the vector
[32], after incorporating a fragment containing the pro-
moter, polylinker, and transcriptional terminators from
pTrc99A (Figure 2).
The initial part of the operon was constructed by
sequential amplification and ligation of the first 4
coding sequences (aroB, tktA, aroGfbr, and aroE) into
the polylinker of plasmid pBRINT-Ts Cm, used as a
cloning scaffold (see Methods). Later, the 4-gene construc-
tion was transferred to the hybrid plasmid pTrc327par in
conjunction with 2 more genes (aroD and zwf), leading to
an 8Kb operon contained in a 12Kb plasmid (Figure 2).
The resulting plasmid, termed pTrcAro6, was transformed
into the PB12 aroK- aroL- strain devoid of the lacIq gene,
Figure 2 (See legend on next page.)
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Figure 2 Simplified scheme of the steps required in the construction of plasmid pTrcAro6, carrying 6 synthetic genes under the
control of the Trc promoter. First, a segment of pTrc99A was amplified and ligated into pBR327par, creating plasmid pTrc327par. A synthetic
operon comprising the required genes (aroB, tktA, aroGfbr, aroE, aroD, and zwf) was assembled separately and transferred to pTrc327par,
generating pTrcAro6. The dotted lines indicate the site and orientation of some of the performed ligation reactions. Only the relevant restriction
sites are displayed. A more detailed scheme of the constructions is presented in Additional file 3.
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(Table 1). For simplicity, the generated PB12 aroK- aroL-
lacI- strain was termed AR2. After the pykF gene was
inactivated in AR2, the resulting strain was named
AR3. Strains derived from AR2 and AR3 carrying
plasmid pTrcAro6 were named AR26 and AR36,
respectively (Table 1).
The spatial arrangement of the coding sequences that
constitute the synthetic operon in pTrcAro6, flanked by
the Trc promoter and transcriptional terminators, is
shown in Figure 2. aroB is the first gene in the operon
since several evidences indicate that its low expression is
one of the limiting steps in the production of aromatic
compounds [33-35]. Plasmid pTrcAro6 also carries the
tktA and aroGfbr genes, whose products are involved in
E4P synthesis and its condensation with PEP to form
DAHP, the first aromatic compound (Figure 1). aroD
and aroE genes were also included to promote an efficient
conversion of DHQ to SA. Additionally, this plasmid carriesTable 1 Escherichia coli strains and plasmids utilized in this re
Strains
Name Characteristics
JM101 F´ traD36 proA + proB + lacIq lacZΔM15/supE thi Δ
PB11 JM101 Δ(ptsH, ptsI, crr)::kan
PB12 PB11, PTS- Glc+; laboratory-evolved
AR2 PB12 lacI- aroK- aroL-
AR3 PB12 lacI- aroK- aroL- pykF-
AR26 AR2 + pTrcAro6 (Trc/aroB+tktA+aroGfbr+ar
AR36 AR3 + pTrcAro6 (Trc/aroB+tktA+aroGfbr+ar
AR2e AR2 + pTrc327par (plasmid vector without s
AR3e AR3 + pTrc327par (plasmid vector without s
Plasmids
Name Characteristics
pKD3 PCR template for amplification of chloramphenicol r
homologous sequences
pKD46 Plasmid expressing λ-Red recombinase system with therm
pCP20 FLP recombinase expression pla
pBR327par Derivative of pBR322 exhibiting increased copy numbe
pTrc99A Multipurpose expression plasmid bearing lacI gene and a p
pTrc327par Contains the promoter, polylinker, and terminators of pTrc99A, a
pTrcAro6 pTrc327par containing a 6-gene synthetic operon to enhanthe zwf gene, coding for the first enzyme of the PPP
(Figure 1). The decision to include this gene was
based on the following observations: 1) the overexpression
of zwf substantially recovered the growth rate loss due to
plasmid metabolic load in strain JM101 growing on
glucose as only carbon source [36]; 2) it has been reported
that strain PB12 displays a particularly low carbon
flux partition at the glucose 6-phosphate (G6P) node
towards the PPP (5% of the consumed G6P compared
to 22% in the parental strain JM101) [25]. Therefore,
an overexpression of this gene should increase NADPH
availability, required in catalytic amounts by the enzyme
shikimate dehydrogenase (AroE), and may alleviate poten-
tial growth affectations by redirecting more G6P towards
nucleotide and amino acid biosynthesis in strains derived
from PB12 [37]. However, the experiments presented in
this report did not aim to dissect the specific effect
of any utilized gene but instead sought to characterize
the consequences of expressing all of them as an operon.port
Reference
(lac-proAB) rpoS(33 am) Messing [41]
Flores et al. [21]; Flores et al. [22]





ynthetic operon) This work
ynthetic operon) This work
Reference
esistance gene flanked by Datsenko and Wanner [42]
osensitive origin of replication Datsenko and Wanner [42]
smid Cherepanov and Wackernagel [43]
r and segregational stability Zurita et al. [32]
olylinker in front of Trc promoter Amann et al. [31]
nd par and ori regions of pBR327par This work (Figure 2)
ce the production of shikimate This work (Figure 2)
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each coding sequence was amplified using designated
primers that introduced a consensus Shine-Dalgarno
sequence located 8 bp upstream of the translation
start site. The nucleotide sequence of the constructed
operon is presented in Additional file 1.
Assessment of the effects caused by pykF inactivation in
strains expressing the Aro6 operon
To evaluate the effects caused by pykF inactivation on
the production of SA, the performance of production
strains AR26 (pykF+) and AR36 (pykF-) was compared
using shake flasks containing 15 g/L of Glc and 5 g/L of
YE. As a control, the same strains containing an empty
pTrc327par plasmid (without the Aro6 operon), AR2e
and AR3e, were also included.
Even though SA accumulated in all cases, as expected
for mutants in aroK and aroL, the strains containing
pTrcAro6 reached higher SA concentrations than the
ones with an empty plasmid (Figure 3b). Moreover, the SA
titer was almost two times higher in AR36 than in AR26
(6.1 g/L vs. 3.3 g/L). A decrease in Glc consumption was
observed in strain AR26 after approximately 18 h of culture,
correlating with high acetate concentration and an arrest in
the production of SA. In contrast, strain AR36 exhibited
constant Glc consumption and negligible amounts of
acetate were produced (Figure 3c, 3d). These results
demonstrate that the genes present in the artificial
operon are functional and promote the production of
SA since the beginning of the culture. Their constitutive
expression diminished the specific growth rate (μ) by 25%
in the pykF+ background, and marginally increased it in
the pykF- variant, but did not cause significant changes to
the maximum biomass produced (Xmax) compared to
strains with an empty plasmid (Figure 3a). Remarkably,
in the operon-expressing strains under these growth
conditions, the inactivation of the pykF gene increased
the production of SA, eliminated the accumulation of
acetate, and allowed steady Glc consumption.
To determine if the higher acetate production and
lower SA production in AR26 compared to AR36 is a
consequence of the inherently low oxygen availability
and acidification of the medium in shake flask cultures,
both strains were cultured in 1 L batch fermentors
under controlled conditions of pH and dissolved oxygen
tension (DOT). As an approach to increase the SA titer,
the initial concentration of Glc in these experiments
was raised to 100 g/L, and the YE concentration was
concomitantly increased to 15 g/L to allow higher
biomass generation.
Under these conditions strain AR36 produced 42 g/L
of SA in 60 h, consuming all the Glc, and accumulating
12 g/L of acetate. In contrast, after 47 h strain AR26 pro-
duced a maximum of 13 g/L of SA, did not exhaust theGlc, and accumulated 29 g/L of acetate (Figure 3e and
Table 2). Regardless of the controlled conditions in the
fermentors, where the pH was kept at 7 and the DOT was
higher than 20% at all times, the production profiles of
both strains resembled the behavior observed in shake
flasks, with AR26 producing more acetate and less SA.
Even when the global volumetric Glc consumption rate
(Qsglobal), μ and Xmax attained by both strains were similar,
the productivity, yield, and titer were more than twofold
higher in AR36 than in AR26 (Figure 3e and Table 2).
It is remarkable that such large differences in acetate
and SA production were observed by disrupting only
one gene, which demonstrates the advantages of the
combined inactivation of PTS and pykF when using a
constitutive expression system in an evolved E. coli
strain. To account for the observed improvements in SA
production, we suggest that the early and constant
expression of enzymes encoded in the operon could
maintain a steady consumption of glycolytic intermediates
throughout the cultures, preventing high fluctuations in
their intracellular concentrations. We hypothesize that the
combination of this steady metabolic state with a reduced
flux from PEP to pyruvate caused by the inactivation of the
pykF gene may increase the availability of PEP and other
glycolytic precursors for SA production without decreasing
the Glc consumption rate. However, we acknowledge that
in the absence of measured intracellular metabolite
concentrations, these remarks are speculative.
Fermentation profiles of AR36 in batch cultures
Taking into account the previous results, AR36 was selected
for further characterization of its kinetic and stoichiometric
performance in 1 L fermentors. To accomplish such
purpose, the production of SA was tested with three
different high-substrate culture conditions. Growth,
Glc and byproducts were measured for each case, which in
turn allowed a comparison of the productivities and yields.
First, 50 g/L of Glc and 15 g/L of YE were utilized
(Figure 4a). Growth occurred during the first 10 h,
generating 6.3 g/L of dry cell weight with a μ of
0.53 h-1. Under this condition, 24 g/L of SA were
produced in 32 h. Glc consumption and SA production
occurred since the beginning of the fermentation and
lasted until Glc exhaustion, although the specific Glc
consumption rate (qs) and specific SA productivity (qp)
were higher in exponential phase (Table 3). The resulting
yield of SA on Glc (YSA/Glc) was 0.47 mol/mol and the glo-
bal volumetric SA productivity (Qpglobal) was 0.74 gSA/
L*h (Table 3). With respect to the accumulation of
byproducts in the SA pathway, concentrations of 2.4 g/L
of DAHP, 2.1 g/L of DHS, 1.4 g/L of QA, 0.4 g/L of GA,
and 0.3 g/L of DHQ, were present in the supernatant at
the end of the fermentation (Figure 5a). Under these
conditions, virtually no acetate was produced during
Figure 3 Behavior of strains AR26, AR36, and their empty-plasmid derivatives, AR2e (pykF+) and AR3e (pykF-), using shake flasks containing
15 g/L of Glc and 5 g/L of YE (a,b,c,d), and 1 L fermentors containing 100 g/L of Glc and 15 g/L of YE (e). a) Growth; b) SA production; c) Glc
consumption; d) acetate production; e) Glc consumption and SA production of AR26 and AR36 in fermentors. Error bars represent standard deviation.
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concentration of 1.5 g/L after 32 h (Figure 4a).
Considering that 50 g/L of Glc were consumed
completely, a second batch experiment was initiated
with 100 g/L of Glc and 15 g/L of YE. As stated in
the comparison with AR26 in the previous section,
AR36 grown under these conditions produced approxi-
mately 42 g/L of SA in 60 h (Figure 4b). In this case, after
consuming about 100 g/L of glucose and attaining the
maximum concentration of SA, the strain produced
12 g/L of acetate. The values obtained for YSA/Glc,
Qpglobal, Qsglobal, Xmax, and μ, were similar to those
obtained with 50 g/L of Glc and 15 g/L of YE
(Table 3). These experiments show that when using
the same YE concentration, twice the amount of Glc
is consumed in almost twice the time, indicating thatthe average glucose consumption rate is maintained
between both culture conditions. Concentrations of
4.8 g/L of DAHP, 2.8 g/L of DHS, 3.4 g/L of QA,
0.7 g/L of GA, and 0.9 g/L of DHQ, were present in
the supernatant after 60 h (Figure 5b). Interestingly,
when doubling the Glc concentration the intermediate
products of the AAA pathway increased in a fairly
proportional manner with the SA, indicating that the
consumption of 100 g/L of Glc did not apparently
generate new carbon flux bottlenecks. As a result,
the amount of SA formed with respect to the total
aromatic compounds produced was close to 80% in
both experiments (Figure 6).
The effect of increasing the YE on SA productivity was
investigated with a third set of experiments, using 100 g/L
of Glc and 30 g/L of YE. Although the biomass was
Figure 4 Fermentation profile of strain AR36 cultivated in 1 L
bioreactors with three different substrate concentrations. a)
50 g/L of Glc and 15 g/L of YE; b) 100 g/L of Glc and 15 g/L of YE; c)
100 g/L of Glc and 30 g/L of YE. Glc: circles; SA: squares; acetate: open
triangles; biomass concentration: inverted triangles. Error bars represent
standard deviation.
Table 2 Comparative data from 1 L batch fermentations
of strains AR26 and AR36, using 100 g/L of Glc and 15 g/L
of YE as substrates
Strain AR26 AR36
SA titer (g/L) 12.95 ± 0.64 41.80 ± 2.83
Glc consumed (g/L) 82.65 ± 4.88 103.70 ± 6.79
Duration of culture (h) 47 60
YSA/Glc (mol/mol) 0.16 ± 0.02 0.42 ± 0.00
Acetate titer (g/L) 29.35 ± 0.21 11.90 ± 0.14
Xmax (g/L) 6.18 ± 0.10 6.54 ± 0.09
μ (h-1) 0.45 ± 0.01 0.45 ± 0.02
Qpglobal (gSA/L*h) 0.27 ± 0.02 0.75 ± 0.07
Qsglobal (gGlc/L*h) -1.76 ± 0.10 -1.73 ± 0.11
YSA/Glc = SA yield from Glc; Xmax =maximum attained biomass expressed as dry
cell weight; Qpglobal = volumetric SA productivity for the entire fermentation;
Qsglobal = volumetric Glc consumption rate for the entire fermentation;
μ = specific growth rate.
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SA titer, μ and YSA/Glc were very similar to those obtained
in the culture with 100 g/L of Glc and 15 g/L of YE
(Figure 4b and Figure 4c). In conjunction with data
obtained from the other two conditions, these findings
suggest that the amount of YE primarily determines the
maximum biomass that can be achieved. Additionally, an
increment in the initial YE concentration did not alter the
SA titer, and supports the observation that SA is mainly
being produced from glucose. The direct relation between
the initial YE concentration and the maximum biomass
generated, regardless of the initial Glc concentration
tested in these growth conditions, suggests that one or
more limiting nutrients are being supplied by the YE.
It would also appear that such nutrients cannot be synthe-
sized from Glc, hence their depletion from YE limits
growth long before Glc is exhausted. It is expected that the
aromatic amino acids and vitamins present in the YE that
are needed to counteract AR36 auxotrophy will become
limiting; however, other compounds in this complex media
may also play a role in growth limitation over time.
For a starting YE concentration of 30 g/L, a total of
106 g/L of Glc and 43 g/L of SA were consumed and
produced, respectively, in approximately half the time
than the fermentation with 15 g/L of YE. With 30 g/L
of YE, the Qsglobal and Qpglobal increased twofold, in
comparison with the fermentations with 15 g/L of
YE, even though the SA titer remained unchanged
(Table 3). Since the biomass also increased twofold,
the calculated qp and qs were similar between the
three experiments, both in exponential and stationary
phases, exhibiting the metabolic robustness of the
engineered strain under the tested conditions.
In addition, the results showed that an increase in
YE concentration did not increase considerably theconcentration of SA pathway intermediates (Figure 5c).
In this respect, it has been acknowledged that the
presence of high quantities of pathway intermediates
can negatively impact the recovery of SA from the
fermentation broth [7,38]. This concern has directed
some efforts into the subject, leading to the testing of
culture conditions, genetic backgrounds, and the use
of non-metabolizable glucose analogs, as attempts to
minimize byproduct generation [39].
In these experiments, a high proportion of SA relative
to byproducts was detected without applying any further
Table 3 Comparison of measured metabolites and calculated kinetic and stoichiometric parameters between three
fermentations of strain AR36 with different substrate concentrations
Strain AR36 AR36 AR36
Culture conditions Batch 50 g/L Glc + 15 g/L YE Batch 100 g/L Glc + 15 g/L YE Batch 100 g/L Glc + 30 g/L YE
SA titer (g/L) 23.80 ± 0.00 41.80 ± 2.83 43.30 ± 0.57
Glc consumed (g/L) 52.65 ± 1.20 103.70 ± 6.79 105.55 ± 4.45
Duration of culture (h) 32 60 30
YSA/Glc (mol/mol) 0.47 ± 0.01 0.42 ± 0.00 0.42 ± 0.01
Acetate titer (g/L) 1.45 ± 0.00 11.90 ± 0.14 8.65 ± 0.92
Xmax (g/L) 6.30 ± 0.09 6.54 ± 0.09 12.54 ± 0.06
μ (h-1) 0.53 ± 0.03 0.45 ± 0.02 0.45 ± 0.00
Qpglobal (gSA/L*h) 0.74 ± 0.00 0.75 ± 0.07 1.44 ± 0.02
Qsglobal (gGlc/L*h) -1.65 ± 0.04 -1.74 ± 0.11 -3.52 ± 0.15
qpexp (gSA/gDCW*h) 0.38 ± 0.00 0.34 ± 0.03 0.46 ± 0.06
qsexp (gGlc/gDCW*h) -1.14 ± 0.15 -1.11 ± 0.00 -1.18 ± 0.03
qpsta (gSA/gDCW*h) 0.16 ± 0.01 0.19 ± 0.02 0.20 ± 0.01
qssta (gGlc/gDCW*h) -0.36 ± 0.01 -0.42 ± 0.01 -0.42 ± 0.03
YSA/Glc = SA yield from Glc; Xmax =maximum attained biomass expressed as dry cell weight; Qpglobal = volumetric SA productivity for the entire fermentation;
Qsglobal = volumetric Glc consumption rate for the entire fermentation; qpexp = specific SA productivity for exponential phase; qsexp = specific Glc consumption rate
for exponential phase; qpsta = specific SA productivity for stationary phase; qssta = specific Glc consumption rate for stationary phase; μ = specific growth rate.
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http://www.microbialcellfactories.com/content/12/1/86modification to the strain or process. The concentration
of each pathway intermediate was compared against the
sum of all aromatic intermediates, and their percentages
were used to calculate the molar ratio of SA to each
byproduct at the end of the fermentations (Figure 6).
The ratio of SA turned out to be higher than 10 for
DHS, QA, or DAHP, and higher than 40 for GA or
DHQ for all the substrate concentrations tested.
Remarkably, in all the conditions the obtained SA yields
were close to 50% of the theoretical maximum and the
yields of total aromatic compounds (TAC) were above
60% of the theoretical maximum, estimated as 0.86
molTAC/molGlc (see Methods and Figure 6). This reflects
the efficient redirection of glucose towards the AAA
pathway in strain AR36, even when using high-glucose
batch cultures. The ratio of SA to byproducts, as well as
the obtained SA and TAC yields are fairly constant
for all the conditions evaluated, and represent to our
knowledge the highest reported values for a SA production
fermentation process. These improvements can be justified
by taking into account that the platform present in the
engineered strain allows a more homogeneous expression
of the necessary enzymes on an efficient genetic
background. This, in contrast with other expression
systems where the required genes are expressed from
separate plasmids, under different promoters, or in
strains not optimized for efficient use of high levels
of Glc. In addition to the advantages concerning the
dynamics of gene expression, the fact that IPTG is
not needed to induce the Aro6 operon represents animportant economical benefit for the production
process, since the high price of IPTG restricts its use
in large-scale fermentations.
Insights on the glycolytic and acetate metabolisms of
strain AR36 by RT-qPCR
To gain a deeper insight of the metabolic changes
induced by the constitutive expression of the Aro6
synthetic operon in strain AR36, transcript levels of
several genes were measured at three different growth
stages in cultures with 50 g/L of Glc and 15 g/L of YE. As
detailed in Methods, data obtained from early exponential
phase (EE), late exponential phase (LE), and stationary
phase (ST) were normalized against the values measured
from strain AR3e at EE, grown under the same culture
conditions.
The results indicate that the presence and expression of
the operon in strain AR36 increases the transcriptional
levels of several genes coding for glycolytic enzymes
during the EE and LE phases (Figure 1 and Figure 7a).
The rise in expression of genes galP and glk is particularly
interesting because it has been reported that their
products control the import and phosphorylation of
glucose in PB12, the parental strain of AR36 [21,25].
Furthermore, there is a significant increase in the
transcriptional levels of pgi and eno, but not pykA. These
changes may translate into higher availability of PEP and
fructose 6-P (which can be directly converted into E4P by
plasmid-encoded transketolase), increasing the yield of
aromatic compounds. We theorize that the observed
Figure 5 Aromatic byproducts of the SA pathway detected in
1 L fermentor cultures of strain AR36 using three different
substrate concentrations. a) 50 g/L of Glc and 15 g/L of YE; b)
100 g/L of Glc and 15 g/L of YE; c) 100 g/L of Glc and 30 g/L of YE.
Diamonds: DAHP (3-deoxy-D-arabinoheptulosonate 7-phosphate);
squares: DHQ (3-dehydroquinic acid); circles: DHS (3-dehydroshikimic
acid); triangles: QA (quinic acid); inverted triangles: GA (gallic acid).
Error bars represent standard deviation.
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be one of the consequences to low levels of some
glycolytic intermediates (glucose 6-phosphate, fructose
6-phosphate and PEP), caused by the strong and con-
stitutive expression of the operon-encoded enzymes
that consume these metabolites.
On the other side, the transcriptional levels of genes
coding for enzymes involved in acetate biosynthesis
(poxB, ackA and pta) were not modified by the presence
of the synthetic operon, while actP and acs, coding
for enzymes involved in acetate assimilation, were
strongly upregulated in the EE and LE phases (Figure 7b).
Upregulation of actP and acs genes has also been detected
in the exponential growth phase in the parental strain
PB12 that is capable of co-utilizing Glc and acetate in
minimal medium [21]. These findings correlate with the
low levels of acetate in the assayed growth condition
(Figure 4a). Importantly, the transcriptional values of
these genes involved in acetate assimilation were low
in ST phase (Figure 7b). If this response is representative
of the other growth conditions used, it could partially
explain the acetate accumulation observed in fermenta-
tions with 100 g/L of Glc, which consume higher amounts
of Glc during stationary phase (Figure 4b and Figure 4c).
These results highlight actP and acs as potential gene
targets to artificially increase their expression in late
culture stages, taking advantage of the expected capabilities
of strain AR36 to utilize simultaneously Glc and acetate,
present in its parental strain PB12 [21,40].
The genes present in the synthetic operon showed
very strong expression levels (even in stationary phase),
reflecting the constitutive nature of the promoter and high
copy number of the plasmid (Figure 7c). These results
correlate with the uninterrupted Glc consumption and SA
production observed during the entire fermentation
(Figure 4a), suggesting that the enzymes coded by the
genes in the operon are present throughout the cultivation
time. It can be seen in Figure 7c that the transcript levels
of aroD and zwf are comparatively higher and lower,
respectively, than the other four genes in the operon. This
observation should be taken with caution because the six
genes in the operon are being compared to the ones
present in the chromosome of reference strain AR3e. Since
the values obtained for the six genes are not normalized
Figure 7 Transcriptional changes resulting from the expression
of Aro6 synthetic operon in strain AR36. For comparison, the
transcription level of each gene was determined at three different
points in the growth curve of strain AR36, grown with 50 g/L of Glc
and 15 g/L of YE (see Figure 4a). All data were normalized against
the values obtained from strain AR3e at early exponential growth
phase. a) Genes coding for glycolytic enzymes; b) genes involved in
acetate assimilation and biosynthesis; c) genes comprised in the
synthetic Aro6 operon (see Figure 1 and Figure 2). Black bars: early
exponential phase; gray bars: late exponential phase; white bars:
stationary phase. Error bars represent standard deviation.
Figure 6 Molar percentage of each aromatic compound produced
in strain AR36 with respect to the total in batch cultures starting
with: a) 50 g/L of Glc and 15 g/L of YE; b) 100 g/L of Glc and 15 g/L
of YE; c) 100 g/L of Glc and 30 g/L of YE. Calculated yields and molar
ratios of the produced aromatic compounds are shown below each
bar. The comparisons were made with the concentrations measured in
the supernatant at the end of the fermentations. YSA/Glc = yield of
SA from Glc; YTAC/Glc = yield of total aromatic compounds from
Glc; Ymax =maximum theoretical yield of aromatic compounds.
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expression in strain AR3e can alter the relative compari-
sons with strain AR36. Nevertheless, the transcriptomic
data is consistent with the high ratio of SA to aromatic
intermediates obtained in the tested conditions, which is to
be expected if all the genes in the operon were adequately
expressed. Together with kinetic and stoichiometric
data, these results highlight the benefits of employing
a constitutively-expressed synthetic operon as an alternate
strategy to increase the yield of SA from Glc in an evolved
strain that lacks PTS and pykF.
Conclusions
E. coli is the microorganism that has given the best
results for SA production, with engineered strains that
can accumulate up to 85 g/L using 10 L fermentors in
fed-batch processes [10]. In this report, we showed that
the constitutive and synchronous expression of a six-gene
synthetic operon, in a laboratory-evolved strain bearing
simultaneous PTS and pykF inactivations, resulted in
a competitive process for the production of SA. The
expression of Aro6 operon in the PTS- pykF- derivativeresulted in higher Qpglobal and similar Qsglobal than its
PTS- pykF+ counterpart. In addition, the Glc consumption
and SA production profiles of strain AR36 are consistent
with the observed increase in transcription levels of glyco-
lytic genes as a response to the constitutive expression of
the operon in this strain. These features translated into
significant improvements in growth and production
parameters in strain AR36 (producing 0.74 gSA/L*h with
54% yield, using 50 g/L of Glc + 15 g/L of YE), compared
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(producing 0.11 gSA/L*h with 26% yield, using 25 g/L of
Glc + 15 g/L YE).
Albeit fed-batch fermentations in the past have given
the best results with respect to SA production, here we
report that under the appropriate conditions, batch cul-
tures of strain AR36 with an initially high concentration
of Glc can also be efficiently used to produce SA.
However, the production profiles obtained suggest
that fed-batch fermentations could also yield good
results with this strain. The fact that the SA production
ceases only when the glucose is exhausted suggests that
higher titers could be achieved by adequate Glc feeding
strategies and improvements in the acetate uptake
capabilities of this strain, considering that it lacks
PTS and could co-utilize Glc and acetate in these
growing conditions. The fermentations reported here
yielded an elevated ratio of SA to other byproducts of
the pathway (10 times more SA than the main byproducts
generated). Besides increasing the SA yield, this behavior
is relevant for purifying SA from the culture broth. In fact,
preliminary experiments concerning SA purification from
the broth obtained from these cultures, resulted in an
almost quantitative purification process (unpublished
results). Furthermore, the highest yield of total aromatic
compounds obtained represents 67% of the theoretical
maximum, demonstrating the efficient redirection of car-
bon to the AAA pathway by strain AR36. Nevertheless,
the relatively low cellular concentration present in the
cultures, even when administering high concentrations of
YE, represents a significant problem to this production sys-
tem because it restricts the productivity of the process.
Other strategies need to be utilized in order to increase the
biomass concentration without increasing the supplemented
YE, which will constitute an important improvement for
scaling-up the process. Minimizing the metabolic load im-
posed by a high-copy plasmid while maintaining a sufficient
gene dosage of the operon, should improve the distribution
of resources that are directed towards biomass generation
and SA production.
Methods
Construction of Escherichia coli derivatives and plasmids
The laboratory-evolved strain PB12, a derivative of PB11
(obtained by the inactivation of PTS in strain JM101
[41]), was the receptor of the genetic modifications
described in this work [21,22,24]. The strains and plasmids
used in this report are listed in Table 1. The chromosomal
inactivations of aroK, aroL, and lacI genes were performed
sequentially by homologous recombination of PCR prod-
ucts [42]. In all cases, plasmid pKD3 was used as a PCR
template in conjunction with tailored oligonucleotides
containing 45 bp homology with the target chromosomal
sequence (Additional file 2). Plasmid pKD46 expressed theRed recombinase system of bacteriophage lambda, and
plasmid pCP20 allowed removal of the chloramphenicol
resistance cassette after each event [43]. Every step was
verified by PCR, identifying the clones that presented the
expected amplicon sizes when using different sets of
oligonucleotides and chromosomal DNA as a template
(Additional file 2). The pykF inactivated gene was
transduced to PB12 aroK- aroL- using a P1 phage lysate
obtained from strain PB28 (pykF::gen) [44]. Transductants
were selected on gentamycin plates (10 μg/ml), and the
inactivation was confirmed by PCR.
The construction of the Aro6 operon and expression
vector was accomplished in several steps (Figure 2 and
Additional file 3). First, aroB, aroGfbr, tktA and aroE
genes were amplified by PCR using Pfu DNA polymerase
and ligated sequentially into the polylinker of plasmid
pBRINT-Ts Cm [45]. Chromosomal DNA from strain
JM101 was used as a template for amplification of the
required genes, with the exception of aroGfbr, which was
amplified from plasmid pJLBaroGfbrtktA [46]. Different sets
of oligonucleotides were employed for the amplification of
each gene (Additional file 2), which also generated flanking
restriction sites and consensus Shine-Dalgarno sequences
(AGGAGG) situated 8 bp upstream of the start of each
coding sequence. The PCR products were inserted into the
polylinker in the following order: aroB in the SmaI site,
aroGfbr in the XhoI site, tktA in the EcoRV site, and aroE in
the ApaI site. Simultaneously, plasmid pTrc327parlacI+
(Additional file 3) was built by ligating a PCR-amplified
fragment containing the lacI gene, Trc promoter, polylinker,
and transcriptional terminators of pTrc99A [31], into the
ScaI and PvuI sites of pBR327par [32]. The 4-gene operon
present in plasmid pBRINT-Ts Cm was amplified by PCR
with a unique set of oligonucleotides (Additional file 1) and
ligated into pTrc327parlacI+ after digesting both with SacI
and XbaI. Later, aroD was amplified by PCR (flanked by
NheI sites) and ligated into compatible XbaI site of
pTrc327parlacI+. Because of our interest in expressing the
operon in a constitutive manner, a lacI- derivative of the
initial pTrc327parlacI+ plasmid (without synthetic operon)
was generated, and called pTrc327par (Additional file 3).
The 5-gene operon was then transferred into SacI and NcoI
sites of pTrc327par, giving rise to pTrcAro5. Finally, the
zwf gene was inserted into the XbaI site, creating a 6-gene
operon in pTrc327par. The resulting plasmid was named
pTrcAro6 and transformed into AR2 and AR3 strains,
generating AR26 and AR36, respectively (Table 1).
The transformed strains were selected in LB plates
supplemented with tetracycline (30 μg/ml).
Each step in the gene cloning and plasmid construction
schemes was screened by endonuclease digestion and PCR,
visualized with gel electrophoresis, and verified by DNA
sequencing (3730, Perkin-Elmer/Applied Biosystems, USA).
All the enzymes and reagents used in the molecular biology
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New England Biolabs (USA). When required, kits for the
purification of PCR, plasmid, and agarose-embedded DNA
were utilized (Roche, Switzerland). TOP10 cells (Invitrogen,
USA) were used as a host for screening of DNA ligations
during intermediate steps in vector construction.
Cultivation media and growth conditions
Composition of production medium
SA production medium (adjusted to pH 7.0 with 10 N
NaOH) contained per liter: K2HPO4 (7.5 g), KH2PO4
(7.5 g), citric acid monohydrate (2.1 g), ammonium iron
(III) citrate (0.3 g), concentrated H2SO4 (1.2 ml), MgSO4
(0.64 g), CaCl2 (0.06 g), (NH4)6(Mo7O24) (0.0037 g),
ZnSO4 (0.0029 g), H3BO3 (0.0247 g), CuSO4 (0.0025 g),
MnCl2 (0.0158 g), CoCl2 (0.00129 g), thiamine (0.001 g),
and betaine (0.234 g) as an osmoprotectant. Tetracycline
(30 μg/ml) was added to inocula and cultures whenever
needed for plasmid maintenance. Glucose (filter-sterilized)
and yeast extract (added before autoclaving) were supplied
at the concentrations indicated for each experiment.
The glucose was purchased from JT Baker (USA) and
the autolysed yeast extract from BD Difco (USA).
Shake flask cultures
The inoculum preparation for the shake flask cultures
started by the addition of 1 ml frozen aliquots to 250 ml
shake flasks containing 25 ml of production medium
supplemented with glucose (25 g/L) and yeast extract
(15 g/L). The inoculum was grown at 37°C and 300 rpm
until mid-exponential phase, and approximately 5% of
the final volume was transferred to the test shake flasks
and incubated under the same controlled conditions
with media containing 15 g/L of glucose and 5 g/L of
yeast extract. Cell growth was measured by monitoring
the optical density at 600 nm (OD600) in a DU700
spectrophotometer (Beckman, USA), and samples were
taken periodically, centrifuged, and the supernatant was
stored at -20°C for metabolite analysis. These experiments
were performed at least in triplicate. All cultures started at
approximately 0.3 OD600.
Fermentor cultures
Batch cultures were performed at least in duplicate
using 1 L autoclavable glass bioreactors (Applikon,
The Netherlands) with 500 ml of working volume.
Bioreactors were connected to an Applikon ADI 1010
BioController and ADI 1025 controllers to monitor
temperature, pH, impeller speed, and dissolved oxygen
tension (DOT). The pH was kept at 7.0 by the addition of
H3PO3 (3.3%) and NH4OH (10%). DOT in the culture
medium was maintained by a continuous supply of filtered
air (1 vvm), and by manually controlling the impeller speed
(ranging from 500 to 1000 rpm) to ensure that DOT waskept above 20% at all times. The inoculum preparation for
the fermentors started by the addition of 1 ml frozen
aliquots to 500 ml shake flasks containing 50 ml of pro-
duction medium supplemented with glucose (25 g/L) and
yeast extract (15 g/L). The strains were grown at 37°C and
300 rpm until mid-exponential phase and approximately
5% of the final volume was transferred from each inocu-
lum to previously prepared bioreactors containing the
production medium. All fermentations were performed in
presence of tetracycline (30 μg/ml). Cell growth was mea-
sured by monitoring optical density at 600 nm (OD600) in
a spectrophotometer (DU700, Beckman, USA), and sam-
ples were taken periodically, centrifuged, and the super-
natant was stored at -20°C for metabolite analysis. All the
fermentations started at approximately 0.3 OD600.
Metabolite quantification
The supernatant from each sample was properly diluted
and filtered through 0.45 μM nylon membranes. Shikimic
acid (SA), 3-dehydroshikimic acid (DHS), 3-dehydroquinic
acid (DHQ), quinic acid (QA), gallic acid (GA), acetic acid,
and glucose (Glc) concentrations were determined by HPLC
using a Waters system (600E quaternary pump, 717 auto-
matic injector, 2410 refraction index, and 996 photodiode
array detectors; USA) equipped with an Aminex HPX-87H
column (300 × 7.8 mm; 9 μm; Bio-Rad, USA). The mobile
phase was 5 mM H2SO4, with a flow rate of 0.5 ml/min,
maintained at 50°C. 3-deoxy-D-arabinoheptulosonate
7-phosphate (DAHP) concentrations were determined
colorimetrically by the thiobarbituric acid assay [47].
This method does not distinguish between DAHP and its
unphosphorylated form, DAH, therefore in this work
DAHP levels correspond to the sum of both compounds.
Data analysis and calculations
The measured concentrations of metabolites and biomass
were normalized to the starting volume conditions to
account for changes derived from pH control in fermen-
tors. Data from independent experiments were averaged
and presented in the corresponding graphs, where the
error bars indicate the standard deviation for each
point. Biomass concentration (X) was determined with
a calibration curve between dry cellular weight and
OD600, resulting in the equation X = 0.3587*OD600.
Specific growth rate (μ) was determined by linearly
fitting the biomass concentration to time during exponen-
tial phase with the following equation: lnX = lnXo + μ*t
(where t is time, and X0 is the biomass concentration at
initial time), displaying R2values >0.97. The yield of SA
from Glc (YSA/Glc) was calculated with the average molar
concentrations of SA and Glc, produced and consumed,
respectively, at the point of highest SA concentration.
The yield of total aromatic compounds from glucose
(YTAC/Glc) was calculated with the combined molar
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point of highest SA concentration. The maximum
theoretical yield of aromatic compounds was previously
estimated as 0.86 molTAC/molGlc for a PTS
- strain growing
on glucose as only carbon source [10]. The global volumet-
ric SA productivity (Qpglobal) and the global volumetric Glc
consumption rate (Qsglobal) were calculated taking into ac-
count the time needed to reach the maximum SA concen-
tration. Besides the previous calculations, linearizations
were made to obtain apparent biomass on substrate (YX/S)
and product on biomass (YP/X) yields. Although these
apparent yields do not take into account the yeast extract
consumption, correlation values for linearizations in all
experiments were found to be >0.95, allowing comparisons
between them. These yields were used to calculate the
specific productivity and specific consumption rate on
the exponential phase (qpexp and qsexp, respectively)
with the following equations: qpexp = YP/X*μ; qsexp = μ/YX/S.
The volumetric productivity and volumetric Glc
consumption rate in stationary phase were determined
by linearization of the first concentration data points
at this stage versus time. The volumetric rates were utilized
for calculation of specific production and consumption
rates at stationary phase (qpsta and qssta, respectively) by
dividing them by the average biomass concentration.
RNA extraction, cDNA synthesis and RT-qPCR analysis
Samples from batch fermentations of strain AR36 with
50 g/L of Glc and 15 g/L of YE were collected for RNA
extraction at early exponential phase, EE (2 h ~ 1 OD600),
late exponential phase, LE (8 h ~ 12 OD600), and station-
ary phase, ST (24 h ~ 17 OD600), to determine gene ex-
pression levels. For comparison of the data, samples
from early exponential phase (3.5 h ~ 1 OD600) of strain
AR3e (bearing an empty pTrc327par plasmid carrying
only the tetracycline-resistance gene, Figure 2) cultured
under the same conditions were also collected and
processed. RNA was extracted using hot phenol equili-
brated with water, and cDNA synthesis was performed
using RevertAid H First Strand cDNA Synthesis kit
(Fermentas, USA) and a mixture of specific DNA primers,
as reported previously [21,24]. qPCR experiments
were performed with the ABI Prism 7300 Real Time
PCR System (Applied Biosystems, USA) using Maxima
SYBRGreen PCR Master Mix (Fermentas, USA) and
reaction conditions previously described [21,24]. The
quantification technique used to compare data was
the 2-ΔΔCT method [48] and the results were normalized
using the ihfB gene as an internal control. The same
reproducible expression level for this gene was
detected in all the strains and conditions analyzed
[24]. All qPCR experiments complied with the MIQE
guidelines for publication of quantitative real-time
PCR experiments [49]. Using cells from two separatefermentations, RNA extraction and cDNA synthesis
reactions were performed for each biological replicate
at the indicated times and the gene expression values
were measured by triplicate for each sample. Average
values were graphed, with error bars representing
standard deviation. Standard deviation was less than
30% in all cases.
Additional files
Additional file 1: Nucleotide sequence of the synthetic operon
constructed in this work and present in plasmid pTrcAro6. The aroGfbr
gene included in this construction was a gift from DuPont™-Genencor®,
therefore its coding sequence cannot be disclosed. Each nucleotide of
aroGfbr is indicated with an “n” except for the ones corresponding to its start
and stop codons.
Additional file 2: Oligonucleotides utilized in this work.
Additional file 3: Detailed scheme of the construction of plasmid
pTrcAro6.
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